Concord Biotech shares fall 5% after bonus issuance approval; board nods authorised capital increase to ₹22 crore

In a regulatory filing, Concord said the board has proposed issuing bonus shares in a 1:1 ratio, with one bonus equity share of ₹1 each for every one fully paid-up equity share of ₹1 held by shareholders. The bonus shares will be issued by capitalising the share premium account, subject to shareholders’ approval.

Further, the board of directors has also proposed increasing its authorised share capital from ₹11 crore to ₹22 crore by creating an additional 11 crore equity shares of ₹1 each. The proposal is, however, subject to shareholders’ approval and will also involve a consequential amendment to the capital clause of the company’s Memorandum of Association.

The pharma major also said that it has a share premium balance of ₹81.97 crore as of March 31, 2026, available for capitalisation for the bonus issue.

The bonus shares are expected to be credited or dispatched within two months from the date of the board meeting approving the issue, i.e., by November 22, 2026.

Concord Biotech Q1 FY27 results

The firm reported a 32.8% year-on-year (YoY) jump in its net profit to ₹58.5 crore in the April-June quarter of the 2026-27 financial year (Q1 FY27), compared with ₹44.05 crore in the same period last year.

Its revenue from operations stood at ₹257.4 crore during the quarter under review, marking a 26.2% YoY increase from ₹204 crore in the first quarter of the 2025-26 fiscal year (Q1 FY26).

Concord Biotech share price trends

At 10:20 AM, Concord Biotech shares were trading at ₹1,504.80 apiece on the National Stock Exchange, tumbling 3.56%.

From the beginning of the year, Concord Biotech shares have increased 17%. Over a month’s time, the stock has advanced 2%, while for a six-month period, it has climbed 52%.

Shares of the firm had hit a 52-week high of ₹1,695 on September 22, 2025, and a 52-week low of ₹987 on April 2, 2026.

According to NSE data, as of September 23, 2026, Concord Biotech has a total market capitalisation of ₹16,323.27 crore.